# Tilray Brands, Inc. (TLRY) stock news and updates

As of October 8, 2026. Source: https://www.clearthesis.ai/updates/TLRY

## Our view on the Tilray Brands, Inc. investment thesis

Full investment thesis: https://www.clearthesis.ai/thesis/TLRY

## Latest updates on Tilray Brands, Inc.

### Revenue rose 23 percent but losses were wider than expected

*October 8, 2026 · earnings · significance: major · signal: neutral*

Tilray reported record first-quarter revenue of $257 million, a 23 percent jump from last year. The growth was led by its beverage business, which brought in $101 million, and a 71 percent surge in its European and Middle Eastern markets. The company also improved its gross margin, the percentage of revenue left after paying for the goods sold, to 30 percent and paid down $42 million in debt. Despite the sales growth, the company lost 32 cents per share, which was wider than the 18-cent loss analysts expected. This highlights the ongoing challenge of turning high sales growth into actual profit. For long-term owners, the takeaway is that the pivot into alcohol and international medical cannabis is working to diversify the business, but the path to consistent profitability remains the main hurdle. The stock fell about 5 percent following the report.

Sources: [8-K filing](https://www.sec.gov/Archives/edgar/data/1731348/000117184326006527/0001171843-26-006527-index.htm)

### Germany issues new guidance for medical cannabis prescriptions

*August 19, 2026 · news · significance: notable · signal: positive*

German health authorities issued new guidance that makes it easier for doctors to prescribe full-spectrum cannabis extracts. This move provides a clearer framework for medical professionals and helps ensure patients can more reliably access these treatments. This is a helpful development for Tilray because Germany is a cornerstone of its international growth plan. As the company works to offset slow growth in the Canadian market, it relies on European medical sales to drive higher profits. Clearer rules for doctors generally lead to more consistent prescribing and higher sales volumes over time.

Sources: [GlobeNewsWire](https://www.globenewswire.com/news-release/2026/08/18/3346700/0/en/tilray-medical-welcomes-progress-in-germany-s-medical-cannabis-framework-and-supports-continued-policy-development.html)

## Tilray Brands, Inc. earnings

In Q1 2027, reported on October 8, 2026, Tilray Brands, Inc. posted earnings of $-0.32 per share against $-0.18 expected, and revenue of $257.1 million against $266.3 million expected.

The next earnings report is expected on October 8, 2026. Analysts expect $-0.18 per share. Revenue is expected around $266.3 million.

What to watch: Whether beverage profit margins stay above 35 percent, which proves the company can make real money from its new craft beer brands.

## What's ahead for Tilray Brands, Inc.

- October 8, 2026: Earnings report — The company shows how it did over the last three months. The most important update for the stock.

---

Published by Clearthesis (https://www.clearthesis.ai). Informational only, not investment advice.
Full page: https://www.clearthesis.ai/updates/TLRY
